New Delhi never approved the company’s jab as the US drugmaker apparently wanted protection from lawsuits over adverse effects.
BROADCASTING FOR INDEPENDENCE
New Delhi never approved the company’s jab as the US drugmaker apparently wanted protection from lawsuits over adverse effects.